Table 1 Protocols for administering vaccines, group sizes, and incidences of deaths and adverse reactions
From: Optimal immunization strategies for Saanen goats against goatpox
Groups | Group size | Age (month) | Vaccination Protocol | Adverse signs | Number of Deaths | |
|---|---|---|---|---|---|---|
| Â | Male | Female | Â | Â | Â | Â |
C | 10 | 15 | 12 | without being administered a vaccine | - | - |
G1 | 75 | 75 | 3 | At three months, the Inactivated vaccine a At four months, the inactivated vaccine At six months, Live vaccine | Minor signs were observed in three animals (2%) | 0 |
G2 | 75 | 75 | 3 | At three months, the Inactivated vaccine At five months, Live vaccine | Twenty-eight cases (18.66%) of mild lesions | 0 |
G3 | 25 | 25 | 3 | At three months, Live vaccine | 41 animals (82%) exhibited signs related to GTPV * | 11 (22% **) |
All groups | - | - | - | Healthy animals are reimmunized annually with live attenuated booster for three years. | Not seen | Not seen |
Total | 185 | 190 | Â | Â | Â | Â |
| Â | 375 | Â | Â | Â | Â | |